JusticeNotableSingle-sourceDeveloping
5.4
Novo Nordisk seeks US injunction against Eli Lilly weight-loss drug advertising
Valor Econômico·US · DK·3 days ago
Anti-trans activists have initiated a High Court bid to challenge the PATHWAYS puberty blocker trial. The outcome remains uncertain as the court must first grant permission for the judicial review to proceed, which could impact the availability of gender-affirming care for minors in the UK.
Locations
Entities